Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia

PURPOSE: Patients with hemoglobin SC (Hb SC) and hemoglobin SB+ (Hb SB+) thalassemia suffer from frequent hospitalizations yet strong evidence of a clinical benefit of hydroxyurea (HU) in this population is lacking. Patients with recurrent hospitalizations for pain crisis are offered HU at our insti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebensburger, Jeffrey D, Patel, Rakeshkumar J, Palabindela, Prasannalaxmi, Bemrich-Stolz, Christina J, Howard, Thomas H, Hilliard, Lee M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687721/
https://www.ncbi.nlm.nih.gov/pubmed/26719735
http://dx.doi.org/10.2147/JBM.S97405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687721/
https://www.ncbi.nlm.nih.gov/pubmed/26719735
http://dx.doi.org/10.2147/JBM.S97405

Ejemplares similares